PHA-739358, a Potent Inhibitor of Aurora Kinases With a Selective Target Inhibition Profile Relevant to Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

Oncotarget
Oncology
2015English

SRC Inhibition Is Still a Relevant Target in Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2014English

Selective Inhibition of IL-Gene Expression by 2Trichostatin A, a Potent Inhibitor of Mammalian Histone Deacetylase.

Journal of Antibiotics
Drug DiscoveryPharmacology
1996English

TheIn vitroandIn vivoEffects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases

Cancer Research
Cancer ResearchOncology
2005English

Aurora Kinases: Structure, Functions and Their Association With Cancer

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2008English

Dictyostelium Aurora Kinase Has Properties of Both Aurora a and Aurora B Kinases

Eukaryotic Cell
2008English

Inhibition of Angiogenesis by Staurosporine, a Potent Protein Kinase Inhibitor.

Journal of Antibiotics
Drug DiscoveryPharmacology
1992English

Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy